What happened
Shares of Protagonist Therapeutics (NASDAQ:PTGX), a clinical-stage biotechnology company, are plummeting today. As of 2:26 p.m. EDT, the stock price has fallen 62.9% in response to news of a clinical hold from the FDA.
So what 
Protagonist…

Click here to view the original article.